tyrosine has been researched along with melphalan in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kozyrev, BM; Rivkind, AI | 1 |
Hoekstra, HJ; Kole, AC; Koops, HS; Molenaar, WM; Nieweg, OE; Pruim, J; Vaalburg, W; van Ginkel, RJ | 1 |
KLATT, O; MILNER, AN; STEHLIN, JS; YOUNG, SE | 1 |
PEREVOSHCHIKOVA, KA | 1 |
Çetinkaya, DU; Özgüneş, H; Özgüneş, N; Öztaş, Y; Sabuncuoğlu, S | 1 |
Kong, FL; Yang, DJ; Young, DP; Yu, DF; Zhang, Y | 1 |
1 trial(s) available for tyrosine and melphalan
Article | Year |
---|---|
Oxidative protein damage with carbonyl levels and nitrotyrosine expression after chemotherapy in bone marrow transplantation patients.
Topics: Antilymphocyte Serum; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Melphalan; Oxidation-Reduction; Protein Carbonylation; Tyrosine | 2012 |
5 other study(ies) available for tyrosine and melphalan
Article | Year |
---|---|
[Electron paramagnetic resonance in solutions of oxidized sarcolysin and other antineoplastic agents].
Topics: Electron Spin Resonance Spectroscopy; Free Radicals; Hydrogen-Ion Concentration; Melphalan; Nitrogen Mustard Compounds; Oxidation-Reduction; Solutions; Tyrosine | 1967 |
L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Hypothermia, Induced; Leg; Male; Melanoma; Melphalan; Middle Aged; Radiopharmaceuticals; Recombinant Proteins; Sarcoma; Sensitivity and Specificity; Skin Neoplasms; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha; Tyrosine | 1999 |
THE BIOCHEMICAL MECHANISM OF ACTION OF L-PHENYLALANINE MUSTARD. I. DISTRIBUTION OF L-PHENYLALANINE MUSTARD-H3 IN TUMOR-BEARING RATS.
Topics: Animals; Bone Marrow; Carcinoma 256, Walker; Chromatography; DNA; Intestines; Kidney; Liver; Melphalan; Metabolism; Muscles; Mustard Plant; Neoplasms; Pharmacology; Phenylalanine; Plasma; Rats; Research; Spleen; Thymus Gland; Tritium; Tyrosine | 1965 |
THE ACTION OF SOME METABOLIC INHIBITORS UPON THE ACCUMULATION OF AMINO ACIDS AND THE INCORPORATION OF THE LATTER INTO THE PROTEINS OF THE TUMOR CELLS IN VITRO.
Topics: Amino Acids; Animals; Antineoplastic Agents; Carcinoma, Brown-Pearce; Carcinoma, Ehrlich Tumor; Glycine; Histocytochemistry; In Vitro Techniques; Lysine; Melphalan; Methionine; Mice; Neoplasm Proteins; Pharmacology; Proteins; Rabbits; Research; Sarcoma; Sarcoma, Experimental; Thiotepa; Tyrosine | 1964 |
Development of (99m)Tc-EC-tyrosine for early detection of breast cancer tumor response to the anticancer drug melphalan.
Topics: Amino Acid Transport System y+L; Animals; Breast Neoplasms; Chelating Agents; Cysteine; Dose-Response Relationship, Drug; Female; Immunohistochemistry; Ki-67 Antigen; Melphalan; Neoplasm Proteins; Organotechnetium Compounds; Radionuclide Imaging; Rats; Rats, Inbred F344; Tissue Distribution; Treatment Outcome; Tyrosine | 2013 |